http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0453159-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d202e9e866984fe229f6facc38f1d740
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D333-34
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D495-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D333-34
filingDate 1991-04-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c7f8b012d61261e35fc0f41295dbc300
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_df76512a89dd164b89e9052ac434906c
publicationDate 1991-10-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EP-0453159-A1
titleOfInvention Synthesis of (S)-3-(thien-2-ylthio)butyric acid analogs
abstract (S)-3-(thien-2-ylthio)butyric acid analogs are intermediates in the synthesis of the chiral (S,S)-5,6-dihydro-4-ethylamino-6-methyl-4H-thieno [2,3-b]thiopyran-2-sulfonamide-7,7-dioxide and analogs thereof, topically effective carbonic anhydrase inhibitors useful in the treatment of ocular hypertension and glaucoma. They are prepared by condensation of 2-mercaptothiophene and (R)-(+)- beta -methyl- beta -propiolactone or an analog thereof.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2009052570-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2821840-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3428715-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2007041796-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7862171-B2
priorityDate 1990-04-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4797413-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4797413-B1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID230684516
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129465587
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2365
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID69191808
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127998199
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID642786
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10176592
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5284549
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID522674
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7799
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419520532
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID416051670
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419548108
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395702
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393770
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226412520
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393487
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129297393
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393636
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10176593
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129239798
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID68120
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID468135900
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419590409
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128759588
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3283
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414586623
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID230264017
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID230264079

Total number of triples: 49.